CITIZENS FINANCIAL GROUP INC/RI
Position in CGTX — Cognition Therapeutics Inc
CIK 759944
PROVIDENCE, RI
Position in CGTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$15,730
+$5,334 QoQ
Shares Held
13,679
0.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 66 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIZENS FINANCIAL GROUP INC/RI holds $49,704,895 across 22 Biotechnology names. CGTX ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50,988 | $25,327,269 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
74,036 | $13,865,462 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,376 | $2,728,611 | |
| 4 | ABCL |
AbCellera Biologics Inc.
|
211,890 | $1,663,336 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,682 | $1,108,392 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
35,148 | $921,580 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,793 | $478,427 | |
| 8 | RPRX |
Royalty Pharma plc
|
7,827 | $438,859 |
All Filings in CGTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,730 | 13,679 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $10,396 | 13,679 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $18,466 | 13,679 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $18,466 | 13,679 | Shares | Defined | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||